Genetic tests

Full name Analytes Gene panels Disease Laboratory
Von Hippel Lindau VHL Von Hippel-Lindau disease Centrum Menselijke Erfelijkheid - KUL
Von Hippel Lindau syndrome VHL Von Hippel-Lindau disease Centrum Medische Genetica - UZ Gent
Paraganglioma-pheochromocytoma (6 genes) - ULG RET, VHL, SDHA, SDHB, SDHC, SDHD Paraganglioma-pheochromocytoma (6 genes) - ULG Hereditary pheochromocytoma-paraganglioma, Von Hippel-Lindau disease, Multiple endocrine neoplasia type 2B, Multiple endocrine neoplasia type 2A Centre de Génétique Humaine - CHU Sart-Tilman
Von Hippel Lindau disease VHL Von Hippel-Lindau disease Centre de Génétique Médicale UCL
Hyperekplexia (gene panel-6 genes) Hyperekplexia (6 genes) - IPG Hereditary hyperekplexia Centre de Génétique-Institut de Pathologie et de Génétique (IPG)
Hyperekplexia (3 genes) SLC6A5, GLRA1, GLRB Hyperekplexia (3 genes) - ULG Hereditary hyperekplexia Centre de Génétique Humaine - CHU Sart-Tilman
Chronic granulomatous disease, X-linked CYBB Chronic granulomatous disease, X-linked mendelian susceptibility to mycobacterial diseases due to CYBB deficiency Centrum Menselijke Erfelijkheid - KUL
CYP2C9*2,*3 genotyping - drug metabolism - Pharmacogenetics CYP2C9 Vitamin K antagonists toxicity or dose selection, Oral antidiabetic drugs toxicity or dose selection Centre de Génétique Médicale UCL
Vitamin K antagonists toxicity or dose selection - VKORC1 genotyping (-1639G>A + 1173C>T) - Pharmacogenetics VKORC1 Vitamin K antagonists toxicity or dose selection, Prediction of toxicity or dose selection of vitamin K antagonists Centre de Génétique Médicale UCL